Page last updated: 2024-12-08

methylisopropylamiloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID160563
MeSH IDM0140190

Synonyms (12)

Synonym
CBIOL_001934
BIO1_000220
BIO1_001198
BIO1_000709
methylisopropylamiloride
1151-74-2
3-amino-6-chloro-n-(diaminomethylidene)-5-[methyl(propan-2-yl)amino]pyrazine-2-carboxamide
5-mipa
pyrazinecarboxamide, 3-amino-n-(aminoiminomethyl)-6-chloro-5-(methyl(1-methylethyl)amino)-
5-(methylisopropyl)amiloride
DTXSID20921627
3-amino-n-carbamimidoyl-6-chloro-5-[methyl(propan-2-yl)amino]pyrazine-2-carboximidic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" A biphasic dose-response curve for HOE-694 and N-methylisopropylamiloride (MIA) suggested that two isoforms (putatively NHE1 and NHE3) are active in the oocyte, 1-cell, and 2-cell stages."( Developmental changes in the management of acid loads during preimplantation mouse development.
Cook, DI; Day, ML; Gibb, CA; Harding, EA; Johnson, MH, 2002
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.32 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]